Golden State Equity Partners Novartis Ag Call Options Transaction History
Golden State Equity Partners
- $182 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,435Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.27 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.25 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$844 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$728 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$602 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $224B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...